A number of recent studies suggest that mitochondrial function is a player in tumor development and progression. In this study, we have used gene expression arrays to examine transcriptional differences between Oxidative Phosphorylation (OXPHOS) competent and OXPHOS impaired human osteosarcoma cells. Genes associated with extracellular matrix remodeling, including members of the metalloproteinases and inhibitors of metalloproteinases (MMP/TIMP) family, urokinase plasminogen activator and its inhibitor Plasminogen-activator inhibitor-1 (PAI1), and CTGF and CYR61
Introduction
The role of mtDNA and OXPHOS alterations in tumor growth has been explored for many decades [1, 2] . However, a number of important discoveries and observations in the last few years suggested that mitochondrial function is a player in tumor development and progression [3, 4] .
With the exception of multiple lipomas associated with some patients with the Myoclonus Epilepsy and Ragged-Red Fibers (MERRF) syndrome [5, 6] , increased cancer prevalence is commonly not reported in patients with mitochondrial defects [7] , suggesting that mitochondrial alterations may play a role in the progression rather than in the initiation of tumor growth. Avadhani and colleagues described a mitochondria-tonucleus stress signaling, as a phenomenon initiated by mtDNA depletion and/or membrane damage and disruption of the mitochondrial membrane potential. These alterations would lead to a sustained increase in cytosolic calcium, which would alter expression of several nuclear genes [8] [9] [10] [11] . They also described that a mitochondrial stress was associated with the induction of an invasive phenotype in otherwise noninvasive cancer cells [10, 11] . Induction of cathepsin L was put forward as a major player for the increased invasiveness [10] . In their system, the stress signal appears to involve activation of NFκB/Rel transcription factors by the inactivation of Ikß through calcineurin-mediated dephosphorylation [9] .
Their data implicate calcium increase in the cytosol as a key mediator of a more aggressive tumorigenic phenotype. Among different Ca ++ -activated pathways, there is precedent for increases in cytosolic Ca ++ also regulating Matrix Metalloproteinases 4 (MMPs) expression and activation [12, 13] . Increased Ca ++ has been shown to activate MMP-2 and to stimulate the degradation of Tissue Inhibitor of Metalloproteinase-2 (TIMP-2), [14] . MMPs can also be regulated at the transcriptional levels by the Calpain Inhibitor CP1B [15] . We now show that the MMP/TIMP system, as well as additional ECM remodeling factors can be regulated at the transcriptional level by OXPHOS activity. These results suggest that specific OXPHOS defects may participate in tumor progression by modulating extracellular matrix remodeling processes.
Materials and Methods.

Cell lines and Culture conditions
Human 143B osteosarcoma cells (obtained from ATCC), 143B ρ° cell line, 143B
CTM and human embryonic kidney (HEK) 293T cells were cultured in high-glucose Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 µg/ml sodium pyruvate, and 50 µg/ml of uridine. Treatment with mitochondrial inhibitors was performed by addition of KCN (1 mM), rotenone (100 nM) or antimycin A (20 nM) to the culture medium. KCN was selected for the microarray experiments because inhibition of cytochrome oxidase at 21% oxygen has been shown to not increase reactive oxygen species formation ( [16, 17] and unpublished observations). Temporary mtDNA depletion was performed as described previously, by growing cells for 15 days in the presence of EtBr (10ng/ml) [18] . Cells grown in hypoxic conditions were incubated for 6 hours in a chamber with 0.5% oxygen, 5% Carbon Dioxide. 143B CTM cell line was created by fusion of 143B ρ° cell line with human platelets carrying wild-type mtDNA as previously described [19] . Southern blot analysis (figure 1) and total respiration measurements (data not shown) of 143B CTM cells confirmed repopulation of 143B ρ° cells with mtDNA and recovery of OXPHOS function.
Southern Blot
Southern blot for mtDNA was performed as previously described [20] . Briefly, total DNA from cells was purified by phenol extraction. Five µg of DNA from each sample was digested with PvuII. Southern blot was analyzed using mtDNA probe corresponding to position 3305-4261. As a loading control, a nuclear 18S rDNA probe was used [21] . Both probes were radioactively labeled by random priming (Roche, Indianapolis, IN).
Microarray Sample Handling
Cell culture conditions were strictly followed in order to prevent experimentally induced gene expression changes. Special care was taken to maintain equivalent cell culture conditions for all experiments. For Incyte experiments, total RNA was isolated using TRIZOL reagent (Life Technologies Rockville, MD). Subsequently, mRNA purification was performed using Oligotex kit (Qiagen, Valencia, CA). The quality of RNA was monitored by Agilent 2100 bioanalyzer before cRNA synthesis. Next, mRNA was labeled using Cy3 or Cy5 labeled probes using LifeArray probe labeling kit (IncyteGenomics, Palo Alto, CA). Incyte human Unigene 1 LifeArrays were hybridized with labeled cRNA at 60ºC for 6 hr following the manufacturers' direction. In order to eliminate dye swap bias, all OXPHOS deficient samples were labeled with Cy3 and untreated 143B samples were labeled with Cy5. A dye swap experiment was performed for 143B EtBr (labeled with Cy5) vs. 143B (labeled with Cy3) to rule out dye bias.
Control comparisons (arrays H-J, Figure 1B) show no significant gene expression changes (figure 1B), validating the experimental procedure as well as documenting the unremarkable effect of EtBr (10 ng/ml) and KCN on gene expression when no change in OXPHOS function takes place.
For Affymetrix experiments, procedures were followed as presented in the Manufacturer's GeneChip Expression Technical Manual (Affymetrix, Santa Clara, CA).
Briefly, TRIZOL was used for RNA isolation according to protocols recommended by the manufacturer. Total RNA in the amount of 5 µg from each sample was used for double strand cDNA synthesis by linear amplification using oligo dT-T7 primer and reverse transcriptase. Subsequently, biotin-labeled cRNA was generated by in vitro transcription (IVT) using the BioArray HighYield RNA Transcript Labeling Kit (ENZO, Farmingdale, NY) followed by cRNA fragmentation. Prior to hybridizing to the expression arrays, the quality of the hybridization target was determined by hybridization to a Test3 array that indicated the efficacy of the RT/IVT reaction by the ratios of expression level of 5' to 3' of housekeeping genes (β-actin and GAPDH). Human U95A, U95B and U95C arrays were hybridized with each of the 5 labeled samples overnight at 
Microarray data management and Statistical Analysis
Incyte Microarray images were acquired and analyzed using Genepix Pro 5.1 (Axon B Instruments, Union City, CA). For global normalization, locally weighted scatter plot smoothing (LOWESS, Cleveland, OH) was used [22] . Data was then filtered for unreliable data points (irregular geometry, scratched, signal to noise ratio less than 3
and/or saturated signal) using Acuity software (Axon Instruments, Union City, CA).
Filtered data was then imported into GeneSpring software for further statistical analysis (Silicon Genetics, Redwood City, CA). The seven OXPHOS deficient arrays were pooled and considered as replicate arrays since all treatments result in an OXPHOS defect. In this way, gene expression changes induced by any particular treatment would not be considered. Control arrays did not result in any significant gene expression changes and were therefore also pooled and considered as triplicate arrays and used subsequently for statistical analysis. One-way-ANOVA was applied to these two groups. For multiple testing correction method, Benjamini and Hochberg False Discovery rate procedure was applied and genes with a p-value less than 0.01 were considered significantly differentially expressed in OXPHOS deficient cells [23] . Gene tree clustering, applying spearman correlation, was then applied on statistically significant genes (p-value less than 0.01). Boxplot was generated using Sigmaplot software (Systat Software, Point Richmond, CA) by plotting lowess M (log ratios of F635 (Cy5) over F532 (Cy3) channel) for each gene in every array.
The Affymetrix dataset was normalized by scaling the target intensity to 150
using Microarray Suite 5.1(Affymetrix). Data was imported into Genespring, each array was then normalized to the 50 th percentile and each gene was normalized to the 143B sample intensity in order to obtain fold changes. U95A, B and C arrays for each condition were pooled and considered as replicates and subjected to one-sample t-test to obtain a gene list of statistically significant gene expression changes induced by OXPHOS dysfunction in all arrays. Functional classification of genelists was performed using
Onto-express [24, 25] according to biological processes in the Gene-Ontology (GO)
category.
Confirmation of transcriptional changes by Real-time RT-PCR
Total RNA was isolated from cells grown at 80% confluency using TRIZOL reagent (Life Technologies, Inc.). cDNA was synthesized by the use of Superscript Firststrand Synthesis system (Invitrogen Carlsbad, CA). Quantitative real time RT-PCR was performed following guidelines described previously [26, 27] . Briefly, quantification of relative transcript levels for MMP1, TIMP1, TIMP2, uPA, CTGF, PAI1 and CYR61, and the housekeeping gene β-actin in the cDNA samples was performed and analyzed using a 
Reporter Gene Assay
For luciferase reporter assays, human embryonic kidney 293T cells were used because of their high transfection efficiency. MMP1, TIMP1 and TIMP2 luciferase reporter plasmids were obtained as reported [28, 29] . For normalization, β-galactosidase [30] .
Results
Changes in gene expression triggered by OXPHOS dysfunction
We performed genome wide cDNA microarray experiments to identify changes in the transcriptome triggered by OXPHOS dysfunction. For this, we used two platforms (Incyte and Affymetrix) of microarray technologies to reduce platform-specific bias. Clustering analysis also showed OXPHOS dysfunction induced gene expression changes that were common to all treatments (arrays A-F) and were not seen in control arrays (arrays H-J) ( figure 1C ).
To rule out platform-specific bias, we performed one-color arrays (U95A-C Affymetrix) for a more limited number of samples. We analyzed 143B, 143B treated with EtBr, 143B∆, ρ° and ρ° treated with EtBr samples. This analysis resulted in 222 genes differentially expressed between OXPHOS dysfunction group and 143B cells with ANOVA p-values less than 0.01 (supplementary table 2 ). Statistically significant genes for both platforms could be grouped into similar distinct functional groups (figure 2). To determine if the changes observed at the transcriptional level in osteosarcoma cells were reflected at the protein level, we performed western blot assays. These experiments showed that OXPHOS dysfunction was associated with a mild increase in the steady-state levels of MMP1 but a marked decrease in the levels of TIMP1 steadystate levels in OXPHOS deficient cells (Figure 4) .
Extracellular-matrix remodeling genes are differentially expressed due to OXPHOS dysfunction
In order to confirm these results in a different cell type, human embryonic kidney 
Discussion
Although several studies have implicated OXPHOS dysfunction in tumorigenesis, the molecular mechanism underlying this relationship remains undetermined. In order to shed light into the cellular processes taking place during OXPHOS dysfunction, genome wide cDNA microarray experiments were performed. To minimize cell-to-cell variations we performed different treatments that cause OXPHOS defects, including mtDNA depletion, no mtDNA and a defective mtDNA. We also analyzed cells exposed to KCN, a pharmacological inhibitor of complex IV.
Microarray studies revealed that differences in gene expression clustered in OXPHOS deficient cells, indicating a common global effect on gene expression. Some of the highly significant genes were involved in extracellular remodeling and we confirmed these changes by quantitative RT-PCR. Notably, the transcription of MMP1 was highly increased, even though we were able to detect only a modest increase at the protein level by western blots. Nevertheless, Kermorgant and colleagues showed that MMP1 participated in matrigel invasion of Caco-2 cells [32] . Conversely, the transcription of TIMP1, an inhibitor of metalloproteinases was decreased in our OXPHOS deficient cells, not only at the transcriptional level but also at the protein level. In addition to its effect on transcription, OXPHOS dysfunction could have an activating effect on extracellular remodeling by having an impaired calcium buffering capacity [8, 33] . Ca ++ is a known activator of MMPs function [13, 14] . This could further explain the increase in invasive phenotype observed in mtDNA deficient cells.
The increased invasiveness of OXPHOS deficient cells has been documented in several studies, and it was previously attributed to cathepsin L over-expression [8, 10, 11] .
Our results suggest that in osteosarcoma cells, the transcription of genes belonging to the MMP/TIMP system is also modulated by OXPHOS function. In addition, urokinase plasminogen activator (uPA) and its inhibitor (PAI1), well established markers of invasive phenotype [34] , had increased transcripts in OXPHOS deficient cells. Likewise, connective tissue growth factor (CTGF) and cystein-rich angiogenic inducer 61 (Cyr61)
were upregulated in OXPHOS deficient cells. CTGF and Cyr61 are part of the CCN family of regulatory factors (the name was coined from Cyr6, CTGF and Nov) involved in many aspects of cell proliferation and differentiation. An increasing body of evidence indicates that abnormal expression of the CCN proteins is associated to tumorigenesis [35] . Increase in the expression of MMPs has also been observed in LMTK -mouse cells harboring mtDNA dimers, which exhibited decreased respiration [36] . Parker and colleagues also showed that PAI-1 was increased in a 143B-derived ρ° cell, a result confirmed by our studies [37] . Miceli and colleagues, using quantitative RT-PCR showed alterations in COL1A1 and COL4A1 (collagen type I alpha 1 and type IV alpha 1) in osteosarcoma ρ° cells, suggesting that additional factors may participate in the increased invasive phenotype [38] .
OXPHOS defects could have an important role in cell migration and invasion.
Because OXPHOS dysfunction somehow mimics lack of oxygen (e.g. both cause increased lactate production and acidification of extracellular environment), which is a common occurrence in solid tumors, one could speculate that cells may have evolved a "get me out of here" response, which would allow them to migrate to a more favorable environment, a concept previously explored in the hypoxia field [39] [40] [41] . Although increased angiogenesis and glucose uptake can be triggered by a block in posttranslational modification of the Hypoxia Inducing Factor 1 alpha (HIF1α) [42] , our results suggest that there may be a more direct mechanism to activate genes involved in remodeling of the extracellular matrix when oxidative metabolism is absent. In fact, Darwinian pressure at the cellular level may select for parallel mechanisms that act in concert to promote cell survival. Godinot and colleagues have shown that defects in OXPHOS correlated to aggressive phenotype of renal carcinomas [43, 44] . Recently, Petros et al. showed that prostate cancer cells have significantly high rates of COXI (cytochrome oxidase subunit I) mutations, which cause OXPHOS dysfuntion [45] . In the same study they showed that PC3 prostate cancer cells harboring homoplasmic levels of a mtDNA mutation in ATPase 6 generated tumors in nude mice that were larger than cells harboring wild-type mtDNA and that these tumors generated significantly higher reactive oxygen species (ROS) suggesting that mtDNA mutations that affect OXPHOS and increased ROS production could contribute to tumor promotion process [45] . Shidara and colleagues showed similar results with cybrids harboring two different mtDNA mutations in the ATPase 6 gene [46] .
The mechanism by which OXPHOS deficiency can lead to transcription activation of extracellular (ECM) remodeling genes is unclear. Constitutive activity of transcriptional factors NF-κB and AP1 has been correlated to some highly invasive cancers [47] . NF-κB/Rel activation has been shown to be induced by OXPHOS dysfunction [9, 48] . It is also well established that MMP1, uPA, PAI1 as well as TIMP1
have binding sites for NF-κB as well as AP1 in their promoters [47, [49] [50] [51] [52] [53] [54] . AP1 binding motif within Cyr61 also seems to play a central role in the hypoxic regulation of this gene [55] .
Although OXPHOS-generated ROS and the levels of superoxide dismutase 2 (SOD2) appear to regulate gene expression of ECM remodeling genes [49, 51, 56] , an OXPHOS effect independent of ROS formation has also been described [48] . Recently, it was shown that wild type von Hippel-Lindau tumor suppressor protein (a regulator of HIF1α) increased mitochondrial DNA and respiratory chain protein contents, providing a link between HIF and OXPHOS transcriptional modulation pathways [57] .
Our results further suggest that OXPHOS dysfunction associated with mtDNA mutations, which are increasingly being observed in tumor cells, could participate in the development of invasive phenotypes. Although ECM remodeling is a complex process, involving a large number of components, we conclude that OXPHOS function is an important player in regulating the transcriptional and steady-state levels of a subset of ECM remodeling factors. To study the levels of MMP1 and TIMP1, conditioned media was prepared as 
